查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1649466

薄膜製药製造市场：预测（2025-2030）

Thin Film Drug Manufacturing Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

薄膜药品製造市场预计在 2025 年价值 73.91 亿美元，预计到 2030 年将达到 101.02 亿美元，预测期内的复合年增长率为 6.45%。

薄膜药物製造是製药业的新兴领域，专注于开发创新的药物输送系统。薄膜是含有活性药物成分（API）的柔性层，可用于各种给药途径，包括口服、舌下、颊部和经皮。这些薄膜可快速溶解和崩坏，为传统锭剂和胶囊提供快速且方便的替代品。该技术因其易于使用而越来越受到支持，尤其是对于难以吞嚥传统剂型的儿科和老年患者。

薄膜製药製造市场驱动因素：

  • 非侵入性药物输送开发的创新：配方技术的进步和对非侵入性药物输送方法的需求不断增加正在推动市场成长。薄膜药物传输系统正在应用于疼痛治疗、神经系统疾病和呼吸系统疾病的治疗。此外，慢性病的增加和个人化医疗的需求进一步推动了这些系统的采用。

市场的主要企业正在大力投资研发，以加强其薄膜配方并扩大其产品组合。薄膜药物输送注重以患者为中心的药物设计，确保更好的生物有效性和快速起效，被定位为一个有前途的创新领域。随着这些产品的监管核准不断增加，预计未来几年市场将显着成长。

薄膜製药製造市场的地理展望：

  • 预计北美将主导市场：预计预测期内北美将占据薄膜製药製造市场的大部分份额。该地区的成长得益于薄膜技术的快速进步、电动帮浦的日益普及、新兴的医疗保健基础设施以及主要市场参与企业的持续产品创新。这些因素促进了消费群的强大和市场稳步发展。

此外，由于职业女性人口的增长和技术先进的吸乳器的需求增加，预计欧洲在此期间将以显着的速度增长。企业进行宣传宣传活动宣传穿戴式吸乳器的好处将大大提高市场渗透率。摘要，由于药物输送技术的创新、对非侵入性治疗方案的需求不断增长、慢性病患病率不断上升、法规环境支持性以及关键区域发展（尤其是北美），薄膜製药製造市场预计将见证显着增长，从而加强这一不断扩大的市场格局。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 收益成长和预测包括国家在内的细分市场和地区分析
  • 公司概况（策略、产品、财务、主要发展等）

薄膜药品製造市场细分如下：

依产品类型：

  • 口腔薄膜
  • 经皮薄膜
  • 其他的

依疾病类型：

  • 思觉失调症
  • 偏头痛
  • 阿片类成瘾
  • 其他的

按分销管道

  • 医院药房
  • 零售药局
  • 其他的

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • 以色列
  • 其他的
  • 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印尼
  • 泰国
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析

5. 薄膜药物製造市场（依产品类型）

  • 介绍
  • 口腔薄膜
  • 经皮薄膜
  • 其他的

第六章 薄膜药物製造市场（依疾病类型）

  • 介绍
  • 思觉失调症
  • 偏头痛
  • 阿片类成瘾
  • 其他的

7. 薄膜药物製造市场（依分销管道）

  • 介绍
  • 医院药房
  • 零售药局
  • 其他的

8. 薄膜製药製造市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Pfizer
  • Novartis
  • ZIM LABORATORIES LIMITED
  • IntelGenx Corp.
  • AbbVie Inc.
  • Roche
  • Nova Thin Film Pharmaceuticals LLC
  • ARx, LLC.
  • LN LABORATORIES
  • Nissha Co., Ltd.
简介目录
Product Code: KSI061617242

The thin film drug manufacturing market is estimated at US$7.391 billion in 2025 and is anticipated to grow at a CAGR of 6.45% during the forecast period and reach US$10.102 billion in 2030.

Thin film drug manufacturing is an emerging sector within the pharmaceutical industry that focuses on developing innovative drug delivery systems. Thin films are flexible layers containing active pharmaceutical ingredients (APIs) designed for various administration routes, including oral, sublingual, buccal, or transdermal. These films dissolve or disintegrate quickly, offering a fast-acting and convenient alternative to traditional tablets and capsules. This technology has gained traction due to its ease of use, particularly for pediatric and geriatric patients who may struggle with swallowing conventional dosage forms.

Drivers of the Thin Film Drug Manufacturing Market:

  • Innovations in Non-Invasive Drug Development: Advances in drug formulation technologies and the rising demand for non-invasive drug delivery methods are driving market growth. Thin film drug delivery systems have therapeutic applications in pain management, neurological disorders, and respiratory conditions. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine further bolster the adoption of these systems.

Major players in the market are investing heavily in research and development to enhance film formulations and broaden their product offerings. The focus on patient-centric drug design, which promises better bioavailability and rapid onset of action, positions thin film drug delivery as a promising area for innovation. As regulatory approvals for these products increase, the market is expected to experience significant growth in the coming years.

Geographical Outlook of the Thin Film Drug Manufacturing Market:

  • North America Expected to Dominate the Market: North America is projected to hold a significant share of the thin film drug manufacturing market during the forecast period. The region's growth can be attributed to rapid advancements in thin film technologies, increased adoption of electric pumps, a well-developed healthcare infrastructure, and continuous product innovations by leading market players. These factors contribute to a robust consumer base and steady market development.

In addition, Europe is anticipated to grow at a notable rate during this period, driven by a rising population of working women and increasing demand for technologically advanced breast pumps. Companies' awareness campaigns promoting the benefits of wearable breast pumps significantly enhance market penetration. Favorable regulations and consumer preferences for innovative healthcare devices will also likely propel market growth in Europe.In summary, the thin film drug manufacturing market is set for substantial growth driven by innovations in drug delivery technologies, rising demand for non-invasive treatment options, increasing prevalence of chronic diseases, supportive regulatory environments, and significant geographical developments-especially within North America-that enhance this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Thin Film Drug Manufacturing Market has been segmented as following:

By Product Type:

  • Oral Thin Films
  • Transdermal Thin Films
  • Others

By Disease Type:

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Geography:

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. THIN FILM DRUG MANUFACTURING MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Oral Thin Films
  • 5.3. Transdermal Thin Films
  • 5.4. Others

6. THIN FILM DRUG MANUFACTURING MARKET BY DISEASE TYPE

  • 6.1. Introduction
  • 6.2. Schizophrenia
  • 6.3. Migraine
  • 6.4. Opioid Dependence
  • 6.5. Others

7. THIN FILM DRUG MANUFACTURING MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Hospital Pharmacy
  • 7.3. Retail Pharmacy
  • 7.4. Others

8. THIN FILM DRUG MANUFACTURING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. Israel
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Pfizer
  • 10.2. Novartis
  • 10.3. ZIM LABORATORIES LIMITED
  • 10.4. IntelGenx Corp.
  • 10.5. AbbVie Inc.
  • 10.6. Roche
  • 10.7. Nova Thin Film Pharmaceuticals LLC
  • 10.8. ARx, LLC.
  • 10.9. LN LABORATORIES
  • 10.10. Nissha Co., Ltd.